Donor-transmitted malignancy in a liver transplant recipient: a case report and review of literature
- PMID: 23242807
- DOI: 10.1007/s10620-012-2501-0
Donor-transmitted malignancy in a liver transplant recipient: a case report and review of literature
Abstract
Donor-transmitted malignancy is a rare complication of organ transplantation. This case illustrates a donor-transmitted adenocarcinoma in a patient 11 months after an orthotopic liver transplant for cryptogenic cirrhosis and hepatocellular carcinoma (HCC). Diagnosis of donor-transmitted malignancy may be challenging and can be confused with HCC recurrence. A timely diagnosis is crucial as a delay may limit treatment options. Biopsy of newly found liver lesions and the use of karyotypic and microsatellite analysis may be essential for diagnosis. Protocols should be in place to help recognize and limit the incidence of donor-transmitted malignancy.
Similar articles
-
Donor origin of a posttransplant liver allograft malignancy identified by fluorescence in situ hybridization for the Y chromosome and DNA genotyping.Transplantation. 1997 Jan 15;63(1):80-4. doi: 10.1097/00007890-199701150-00015. Transplantation. 1997. PMID: 9000665
-
Donor transmission of malignant melanoma to a liver graft recipient: case report and literature review.Clin Transplant. 2009 Aug-Sep;23(4):571-4. doi: 10.1111/j.1399-0012.2008.00928.x. Clin Transplant. 2009. PMID: 19681978 Review.
-
The Onset of de novo Hepatocellular Carcinoma after Liver Transplantation can be both of Donor and Recipient origin. A Case Report.J Gastrointestin Liver Dis. 2015 Sep;24(3):387-9. doi: 10.15403/jgld.2014.1121.243.gpp. J Gastrointestin Liver Dis. 2015. PMID: 26405713
-
Long-term recurrence-free survival after liver transplantation from an ABO-incompatible living donor for treatment of hepatocellular carcinoma exceeding Milano criteria in a patient with hepatitis B virus cirrhosis: a case report.Transplant Proc. 2012 Mar;44(2):565-9. doi: 10.1016/j.transproceed.2012.01.029. Transplant Proc. 2012. PMID: 22410070
-
Liver transplantation for hepatocellular carcinoma.Abdom Radiol (NY). 2018 Jan;43(1):185-192. doi: 10.1007/s00261-017-1217-1. Abdom Radiol (NY). 2018. PMID: 28634617 Review.
Cited by
-
Donor transmitted and de novo cancer after liver transplantation.World J Gastroenterol. 2014 May 28;20(20):6170-9. doi: 10.3748/wjg.v20.i20.6170. World J Gastroenterol. 2014. PMID: 24876738 Free PMC article. Review.
-
HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinoma.J Transl Med. 2015 Dec 11;13:379. doi: 10.1186/s12967-015-0743-2. J Transl Med. 2015. PMID: 26653219 Free PMC article.
-
Case report: A successful clinical experience of transplantation of liver and kidney from a donor with myelodysplastic syndromes.Front Immunol. 2024 Apr 3;15:1360955. doi: 10.3389/fimmu.2024.1360955. eCollection 2024. Front Immunol. 2024. PMID: 38633259 Free PMC article.
-
Donors With Previous Malignancy: When Is It Safe to Proceed With Organ Transplantation?Transpl Int. 2025 Jan 24;38:13716. doi: 10.3389/ti.2025.13716. eCollection 2025. Transpl Int. 2025. PMID: 39926359 Free PMC article. Review.
-
Liver Transplantation From Donors With a History of Malignancy: A Single-Center Experience.Transplant Direct. 2017 Oct 18;3(11):e224. doi: 10.1097/TXD.0000000000000738. eCollection 2017 Nov. Transplant Direct. 2017. PMID: 29184912 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical